Related Activities at the 10th China Bioindustry Convention & 1st Guanzhou International Bio-Forum

Feb 27 2019

Share this article

1. Inauguration ceremony

WEN Guohui, CHEN Zhiying, YE Niuping, the city leaders and chiefs of Xiangxue Pharmaceutical Co., Ltd, ICAP and, SFUND, unveiled the nameplate of GUANGZHOU BIO, Guangzhou Bio-Pharmaceutical Industry Investment Fund, and Guangzhou Emerging Industry Development Fund Management Co., Ltd, at Zhaoqing Room.


   
Leaders and guests unveiled the nameplate of GUANGZHOU BIO,
Guangzhou Bio-Pharmaceutical Industry Investment Fund,
and Guangzhou Emerging Industry Development Fund Management Co., Ltd.
 
Leaders and guests attended the inauguration ceremony


   
CHEN Zhiying, member of CPC Guangzhou Standing Committee
and Deputy Mayor of Guangzhou,
attended the inauguration ceremony
and made a speech
 
ZHOU Jianjun, director of Guangzhou Municipal Development
and Reform Committee,
hosted the inauguration ceremony
 
Group photo of leaders at the inauguration ceremony



2. Signing Ceremony


US Harvard Innovation Academy planned to invest and establish Guangzhou Harvard Innovation Academy and signed strategic cooperation agreement with Guangzhou Development Zone on July 3rd.
     
 

A contract-signing of “Thousand Talents Program” Specialist Project
 
Framework Agreement Signing Ceremony for Dino-Israel Guangzhou Development District E-Medicine Collaboration Project



3. Innovation and Entrepreneurship Competition

It incorporated the quarter-final of the 6th China Innovation and Entrepreneurship Competition - Bio-pharmaceutical Industry, with 108 teams and 720 audience.


 

Site of the Innovation and Entrepreneurship Competition
 
Live interactive activities at the Innovation and Entrepreneurship Competition

 
   
 

Evaluation process at the Innovation and Entrepreneurship Competition
 
Site of the Innovation and Entrepreneurship Competition



4. Information release





Release of the Annual Report on Bioindustry in China at the Thirteenth Five-year Biological Policy Roundtable


At the Thirteenth Five-year Biological Policy Roundtable Forum, the High-tech Industry Division of the National Development and Reform Commission and the China Bioengineering Society jointly released the Annual Report on Bioindustry in China: 2016. The Report focused on the seven major chapters, systematically sorted out the overall context, policies and milestones of the development of the bio-industry in 2016, elaborated on bio-industry development strategies and policies, bio-industry development status and trends, biotechnology development frontiers and hotspots. In addition, it showed and analyzed the Chinese bio-industry from multiple perspectives and deeply considered and discussed the Chinese bio-industry development strategy.




Site of the release of the Annual Report on Bioindustry in China: 2016 at the Thirteenth Five-year Biological Policy Roundtable


The Report pointed out that in 2016, the scale of China's bio-industry reached about 4 trillion yuan, and the growth rate of main business income and total profit was much higher than the average growth rate of industrial and high-tech industries in the same period. Artemisinin, genetic testing, super rice and other products and services have been in the world's first echelon, forming a good pattern of accelerated development of the bio-industry.

According to the Report, in the global patent application for tumor immunotherapy, the number of applications from Chinese sources has increased rapidly in recent years. The annual application volume has surpassed that of Japan and Europe and has gradually approached the United States. Both R&D and patent applications are very active. Cellular immunotherapy is an emerging tumor immunotherapy in recent years. Specific CAR-T cell therapy is currently a research and development hotspot. Although the application volume is small, it has a good development prospect and is expected to become another breakthrough direction beyond the immune checkpoint. China's research and development in this field follows the United States and is expected to achieve greater achievements.

The holding of this forum would provide valuable references for the future development of the bio-industry, and as an important record carrier for the development of China's bio-industry, Annual Report on Bioindustry in China:2016 provided an important perspective for the community to observe and understand the history, current situation and development prospects of China's bio-industry.



5. Guangzhou Bio-industry Electronic Map


From experts and scholars to the general public, can intuitively understand the status of Guangzhou's bio-industry through simple and clear touch screen operation and if inputting http://hp.map.y-create.cn on the computer, the whole picture and development trend would be shown.

Event News Search
More Event News

About Forum

In order to further expand the international brand influence, the China Bioindustry Convention will cooperate with a number of internationally renowned organizations, not only to promote Chinese bioindustry in these overseas countries, but also to introduce international professional activities in the biological field to China...